Ulta Beauty Tumbles Early After Mixed Earnings Beat
Ulta Beauty beat earnings and revenue expectations in the latest quarter, but investors focused on margin pressure an...
Why Use Index Level Instead Of Stock Price
Using index level provides a macro view of market direction, helping you balance stock-specific decisions with overall sentiment.
27,685 articles
Japan’s Second-Largest Bank Considering Jefferies Takeover
A Tokyo-based lender is weighing a potential Jefferies takeover, a move that could reshape cross-border banking and i...
Missed Micron’s 811% Surge? There’s Still Upside Ahead
Analysts argue the Micron rally isn’t over: AI memory demand and persistent supply tightness could propel shares high...
Chip Rally: AMD Jumps, Intel Climbs, Broadcom Rises
AMD leads a chip stock rebound with a 7% jump, followed by Intel and Broadcom, as analysts frame the pullback as a bu...
Reasons I’m Buying Amazon Through Late 2026: AI and AWS
Amazon enters the back half of 2026 with sustained AWS growth, a scaling silicon stack, and a resilient Prime-driven ...
Options Traders Bet $550M Against Tesla Ahead of Earnings
A wave of options activity suggests a bearish tilt for Tesla ahead of its Q2 earnings, with net short delta near $550...
NVIDIA’s $65.7 Billion Here Tests the Q4 Market Pulse
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...
Guggenheim Analyst Predicts Oracle FCF Waterfall Ahead
A Guggenheim note argues Oracle's near-term cash burn from AI infrastructure will flip to a strong free cash flow wat...
Warren Buffett’s Coca-Cola Investment: A Long-Term Win?
A timely look at Warren Buffett’s Coca-Cola investment and how Berkshire’s KO stake has powered decades of dividend g...
Wall Street Turns Less Bearish on Airbnb as Target Rises
Airbnb posts a solid Q4, prompting Truist to lift its target to $129 and move the stock to Hold. The shift signals a ...
NVIDIA Could Sales Weren’t If One Bottleneck Lifts AI Demand
NVIDIA faces a supply bottleneck at its chipmaker that could cap near-term revenue even as AI demand remains strong. ...
Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status